Post

CDC Addresses Intraveneous use of Peramivir for Treatment of H1N1

10-25-09: CDC issues letter and information regarding use of the investigational antiviral drug Peramivir intraveneously in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.

Commands